Skip to main content
    V

    VivoSim Labs, Inc. (VIVS)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.12
    -0.00 (-2.91%)

    Market Cap: $2.51M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    VivoSim Labs, Inc. (VIVS) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    VivoSim Labs (VIVS) trades at 14.6x sales and 0.3x book value. Its P/B of 0.3x is below its 5-year median of 1.3x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales14.6x
    Price to book0.3x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/B is 90.0% below 3.0x.

    MultipleCurrent5-year median10-year median
    P/B0.3x1.3x3.0x
    Medians of month-end values through Oct 2026: 57 months (5-year) and 115 months (10-year).

    Valuation History

    Over the 6 of the 10 year ends shown that have a P/S, its P/S ranged from 4.3x in 2019 to 81.1x in 2016.

    Year endPriceP/EP/SP/B
    2025$1.811.7x25.7x1.1x
    2024$5.52N/AN/A1.2x
    2023$13.33N/A33.1x1.6x
    2022$16.93N/AN/A6.6x
    2021$43.58N/AN/A12.1x
    2020$147.66N/AN/A48.8x
    2019$86.43N/A4.3x1.6x
    2018$229.80N/A30.6x3.1x
    2017$321.73N/A32.7x3.0x
    2016$813.93N/A81.1x4.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    Frequently Asked Questions About VIVS

    What is VIVS's price to sales ratio?

    VivoSim Labs has a price to sales ratio of 14.6x.